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ABSTRACT 
Woods, J.H.: Benzodiazepine dependence studies in animals: an overview. Drug Dev. 
Res. S1:077-081, 1982. 
A selective review of benzodiazepine dependence studies in animals is presented, em- 
phasizing areas of drug self-injection, drug discrimination, and physiological dependence. 
Benzodiazepines as a class, as well as long-acting barbiturates, appear to maintain drug 
self-injection behavior less well than ultrashort-acting barbiturates. The duration of action 
as well as the rapidity of onset of these drugs may be important determinants of their 
reinforcing efficacy. Drug discrimination procedures may allow evaluation of the relative 
rapidity at onset and duration of action of these drugs to evaluate this and related hy- 
potheses. 
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INTRODUCTION 
A discussion of the abuse potential of a drug or drug class must first establish its rules of 
evidence for such potential. One important methodological guide for gaining evidence of abuse 
potential is that of pharmacological equivalence [Martin, 19771. If the drug in question is shown 
to be pharmacologically equivalent to a standard drug that has demonstrated abuse potential, the 
comparison drug can also be assumed to have abuse potential. The determination of pharmacological 
equivalence involves comparisons of a series of dose-effect relations involving measures of potency 
and efficacy against a standard or standards of reference. One appropriate test in this situation is 
to evaluate the ability of both the standard and test compounds to maintain self-administration 
behavior. Another test of pharmacological equivalence that may be relevant to abuse potential is 
evaluation of the similarity of the discriminative stimulus properties of a standard and a comparison 
drug. Tests of equivalence of physiological dependence have been used to evaluate the abuse 
potential of narcotics, a procedure that is likely to be relevant to sedatives and anxiolytics as well. 
Address reprint requests to Dr. James H.  Woods, PhD, Department of Pharmacology, University of Michigan 
Medical School, Ann Arbor, MI, 48109. 
0272-4391/82/0081-0077$02.00 0 1982 Alan R. Liss, Inc. 
78 Woods 
A drug’s abuse potential, once determined, must be weighed against its therapeutic potential, 
again using a series of dose-effect relations. As Thompson [I9771 pointed out, an ideal drug would 
produce therapeutic effects at doses below those necessary to maintain drug self-administration. 
To be specific to this presentation, one would want measures of potency and efficacy of the various 
benzodiazepines in tasks predictive of their therapeutic use, namely, the treatment of situational 
anxiety, insomnia, and convulsive disorders, including the alcohol-withdrawal syndrome. This 
information could then be compared to the data on abuse potential. Ideally, all of these data would 
be obtained using tests, species, and routes of administration that have been shown to be predictive 
in human studies. 
This paper is directed toward a discussion of issues concerning the abuse potential of anx- 
iolytics as measured by evaluation of their discriminative stimulus properties, reinforcing properties, 
and potential for producing physiological dependence. 
Stimulus Functions of Barbiturates and Benzodlazepines 
Drugs that have demonstrated abuse potential in man have, in a vast majority of the cases 
iested, also been shown to be both reinforcing stimuli and discriminative stimuli in nonhuman 
primates. A reinforcing stimulus is one that has the capacity to increase and maintain behavior that 
results in delivery of the stimulus. A discriminative stimulus is one in whose presence a particular 
behavior has been reinforced; the behavior is therefore likely to reoccur in the presence of that 
stimulus. Studies of the reinforcing and discriminative functions of benzodiazepines, especially in 
comparison to barbiturates, has provided some provocative information concerning the abuse po- 
tential of this class of drugs. 
Drug Self-lnjection in Primates 
In studies of drug self-injection of the benzodiazepines in nonhuman primates, there have 
been two procedures used. In one type of study, often referred to as a continuous-access self- 
injection study, the primate is given opportunity, without restriction, to self-inject dose units of 
the drug. The results allow the determination of pattern and amount taken over time, and perhaps 
as importantly, observation may be made of the form and severity of intoxication that is self- 
induced under these conditions. It has been shown that severe intoxication may be demonstrated 
with this procedure with barbiturates, narcotics, and central nervous system stimulants [Deneau et 
al., 19691. Yanagita and Takahashi [ 19701 reported that intravenous availability of 3 mg/kg/inj. 
pentobarbital resulted in the initiation and maintenance of self-injection responding in five of five 
monkeys. The amounts of drug delivered per day rose over the course of weeks and the monkeys 
spent considerable periods of time comatose-several multiples of the anesthetizing dose often 
being administered in a single day. A severe withdrawal syndrome was observed upon abrupt 
termination of the opportunity for self-injection. In comparison, availability of intragastric pen- 
tobarbital at 10 mglkgiinj. was sufficient to initiate five of seven monkeys with an average barbiturate 
intake of approximately 120 mg/kg/day at the end of 4 weeks of exposure; intake continued to 
climb until some of the monkeys were injecting over 400 mglkglday after 10 or more weeks. In 
contrast, phenobarbital, at a dose of 7 .5  mg/kg/inj. i.v., did not yield enough self-injection to 
produce signs of intoxication [Deneau, as reported in Fraser and Jasinski, 19771. With intravenous 
diazepam, using 0.4 mgikglinj., Yanagita and Takahashi [1973] reported an intake of 8 to 10 mgl 
kg/day in rhesus monkeys. Severe signs of intoxication were absent throughout the chronic self- 
administration period, although the monkeys were drowsy, ataxic, and less active. With chlordi- 
azepoxide at 1 mg/kg/inj., three of four monkeys took up to a maximum of 31 injections but within 
4 weeks were taking only a few injections each day. In two studies, monkeys with histories of i.v. 
stimulant self-injection were allowed access to intragastric chlordiazepoxide (10 mg/kg/inj .) or 
oxazepam (10 mg/kg/inj.); neither drug condition produced significant amounts of drug intake or 
intoxication. With these data, it is apparent that pentobarbital maintains significantly more behavior 
and self-intoxication than these benzodiazepines. However, only limited conditions (e.g., a single 
dose) have been studied with small numbers of monkeys. In addition, it is difficult to grasp the 
type and degree of drug effect obtained from the observational data presented. 
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In the second type of drug self-injection procedure used to evaluate benzodiazepines, monkeys 
are trained to self-inject a drug during a limited period of time each day. Various doses of other 
drugs are periodically substituted for the standard drug and are thereby assessed for their capacity 
to maintain drug-reinforced responding (substitution procedure). The rate of responding maintained 
by each drug under optimal dose conditions is taken as an indication of the reinforcing strength 
of the drug. Using this procedure, Hoffmeister [1977] found with i.v. drug delivery in rhesus 
monkeys that diazepam is more potent than pentobarbital; each drug maintained rates above saline 
at certain doses, but all doses maintained rates below those of codeine, the standard drug with 
which responding was initiated and maintained. Hackett and Hall [ 19771 failed to obtain rates of 
responding with diazepam (0.05 to 0.4 mg/kg/inj.) above vehicle controls in rhesus monkeys trained 
to inject codeine. As others [Griffiths and Ator, 19811 have noted, procedural details may be of 
considerable importance in producing these differences in diazepam self-injection. It should not 
be overlooked, nevertheless, that neither pentobarbital nor diazepam maintained self-injection 
responding as effectively as codeine in either study. More recently, Winger [personal communi- 
cation] has studied self-injection of a series of barbiturates and benzodiazepines in rhesus monkeys 
maintained on a fixed-ratio 30, timeout 10 minute schedule of i.v. methohexital delivery. Under 
these conditions, 1 .O mg/kg/inj. methohexital maintained rates of responding of over 1 response/ 
see. Both lower and higher doses maintained lower rates of responding. Midazolam, a water soluble, 
short-acting benzodiazepine [Brown et al., 19791 maintained intermediate (30% of methohexital) 
rates though definitely above rates maintained by saline administration. The optimal rate-maintaining 
dose was 0.10 mg/kg/inj. Neither diazepam (0.032 to 1.0 mg/kg/inj.) nor phenobarbital (0.1 to 10 
rnglkglinj. ) was distinguishable from vehicle as far as rates of self-administration were concerned. 
Pentobarbital maintained rates slightly above those produced by saline at 1 .O mg/kg/inj. 
Here, it is important to note that the schedule of drug delivery allows opportunity for injection 
every 10 min, thus favoring, in terms of rate maintenance, those compounds that have rapid onsets 
and brief durations of action. Nevertheless, a difference in rates of drug self-injection persists 
between the benzodiazepines and barbiturates with this procedure when comparing midazolam and 
methohexital, two compounds with rapid onsets and brief durations of action. 
Using a similar procedure with baboons that were allowed 3 hr between opportunities to 
inject a drug solution, Griffiths and colleagues [personal communication] studied a variety of 
barbiturates and benzodiazepines. The baboons were originally trained to self-inject cocaine. Upon 
substitution, amobarbital, secobarbital, and pentobarbital were found to be similar in potency and 
efficacy in maintaining self-injection performance, with virtually all available injections being taken 
at high rates at the optimal doses (3.0 to 10.0 mg/kg). None of the benzodiazepines-clonazepam 
(0.01 to 10mg/kg), clorazepate(0.01 to3.2mg/kg), diazepam(0.3 to  10mg/kg), flurazepam(O.1 to 
32 mg/kg), medazepam (0.01 to 10 mg/kg), and midazolam (0.03 to 10 mg/kg)-maintained rates 
of self-injection comparable to the barbiturates. Two benzodiazepines (clonazepam and flurazepam) 
appeared to maintain self-injection performance slightly above vehicle, while midazolam maintained 
higher rates, clearly intermediate between the rates maintained by the barbiturates and vehicle. 
Thus, a fair correspondence between these studies in the rhesus monkey and the baboon exist with 
the generalization of the limited reinforcing effects of benzodiazepines continuing to be a consistent 
finding. 
Drug Discrimination Studies in Primates 
In a variety of animals, including rats [Colpaert et al., 19761, pigeons [Herling et al., 19801, 
and rhesus monkeys [Winger and Herling, in press] the discriminative characteristics of barbiturates 
and benzodiazepines are somewhat similar. For example, Colpaert and his colleagues examined 
the ability of a variety of compounds to substitute for oral chlordiazepoxide (5 mg/kg) when this 
drug was used as a discriminative stimulus in rats. Bromazepam, diazepam, flurazepam, lorazepam, 
nitrazepam, oxazepam, as well as pentobarbital, phenobarbital, and glutethimide produced drug- 
appropriate responding, while thalidomide, baclofen, chlorpromazine, and haloperidol did not. In 
the monkey, diazepam, methohexital, clobazam, phenobarbital, and barbital produce full drug- 
appropriate responding in monkeys trained to discriminate s . ~ .  injections of pentobarbital from 
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saline, whereas ethylketazocine and dextromethorphan produce very little drug-appropriate re- 
sponding, and codeine, dextrorphan, ketamine, and cyclazocine produce intermediate amounts 
I Winger and Herling, in press]. These studies of drug discrimination, although using different 
routes of administration from the drug-injection studies, suggest that the interoceptive effects of 
barbiturates and benzodiazepines are similar. We shall return to this point in the discussion of the 
human self-administration of benzodiazepines. 
Using drug discrimination procedures it is possible to measure the time of onset and the 
duration of action of drugs that generalize to the training drug. So far, the data on the temporal 
course of the discriminative effect of barbiturates is related to their ability to maintain self-injection 
responding, in that methohexital has the most rapid onset and the shortest duration; with pento- 
barbital, onset is delayed and duration of action lengthened [Winger and Herling, in press]. Thus, 
barbiturates with rapid onsets and short durations of discriminative effects may have stronger 
reinforcing effects than their slower-acting relatives. Benzodiazepines are currently being evaluated 
in this procedure. The S.C. routes of benzodiazepine delivery give unreliable behavioral effects in 
keeping with their poor, rather erratic absorption from these sites. Oral administration produces 
less variable data, and indicates relative rapidity of onset of effects in the following order: pen- 
tobarbital > phenobarbital = diazepam = clobazam. 
Drug Self-Administration Studies in Man 
There have been few quantitative controlled studies of barbiturate or benzodiazepine self- 
administration in humans. Griffiths et al. [1976, 19791 demonstrated that subjects with a history 
of sedative abuse, housed in a residential ward, would self-administer both diazepam and pento- 
barbital via the oral route, whereas they would not self-administer placebo or active doses of 
chlorpromazine. Pentobarbital (90 mg) maintained behavior more consistently than diazepam (20 
mg). In a drug preference study [Griffiths et al., 19801, 400 mg of oral pentobarbital was compared 
to 200 mg of oral diazepam in sedative abusers. Both drugs were preferred to placebo and, at these 
doses, produced similar subjective-effect ratings. When compared to each other, the preference 
was virtually completely in favor of pentobarbital. Thus, the findings that preference and subjective 
rating do not go hand in hand may in some way be related to the fact that the monkeys report the 
similarity of their discriminative effects but self-inject barbiturates at higher rates. 
Physiological Dependence and Tolerance 
Very little is known about direct physiological dependence development to benzodiazepines 
in animals [Fraser and Jasinski, 19771. Nevertheless, a variety of animals have been made phy- 
siologicaly dependent to either ethanol or a barbiturate. Benzodiazepines have been studied more 
extensively as suppressors of withdrawal syndromes. Reliable methods exist for evaluating the 
suppression of these withdrawal syndromes. It is, however, worth bearing in mind that, unlike the 
narcotics of the morphine type, there are compounds that suppress barbiturate withdrawal that do 
not induce dependence upon their chronic administration. These compounds are carisoprodol and 
tybamate [Fraser and Jasinski, 19771. It would be appropriate, therefore, to administer a new 
compound of interest on a chronic basis to insure an appropriate comparison for pharmacological 
equivalence. 
Although it is said often, it bears stating again that proper care must be given to insure that 
the animal is intoxicated a significant portion of the 24-hr period if not continuously. Likewise, 
if long-acting compounds are used, the withdrawal syndrome may not occur until long after drug 
discontinuance. There are a number of good reviews contained in recent volumes [Thompson, 
1977; Martin, 19771 dealing with issues relevant to dependence on benzodiazepines. 
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